tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - karcinom, pljučni pljuč - antineoplastična sredstva - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
crestor 10 mg filmsko obložene tablete
astrazeneca ab - rosuvastatin - filmsko obložena tableta - rosuvastatin 10 mg / 1 tableta - rosuvastatin
crestor 5 mg filmsko obložene tablete
astrazeneca ab - rosuvastatin - filmsko obložena tableta - rosuvastatin 5 mg / 1 tableta - rosuvastatin
crestor 20 mg filmsko obložene tablete
astrazeneca ab - rosuvastatin - filmsko obložena tableta - rosuvastatin 20 mg / 1 tableta - rosuvastatin
crestor 40 mg filmsko obložene tablete
astrazeneca ab - rosuvastatin - filmsko obložena tableta - rosuvastatin 40 mg / 1 tableta - rosuvastatin
dutelas 0,5 mg mehke kapsule
actavis group ptc ehf. - dutasterid - kapsula, mehka - dutasterid 0,5 mg / 1 kapsula - dutasterid
rustavo 10 mg filmsko obložene tablete
teva b.v. - rosuvastatin - filmsko obložena tableta - rosuvastatin 10 mg / 1 tableta - rosuvastatin
rustavo 20 mg filmsko obložene tablete
teva b.v. - rosuvastatin - filmsko obložena tableta - rosuvastatin 20 mg / 1 tableta - rosuvastatin
rustavo 40 mg filmsko obložene tablete
teva b.v. - rosuvastatin - filmsko obložena tableta - rosuvastatin 40 mg / 1 tableta - rosuvastatin
rustavo 5 mg filmsko obložene tablete
teva b.v. - rosuvastatin - filmsko obložena tableta - rosuvastatin 5 mg / 1 tableta - rosuvastatin